Description
This session highlights the evolving role of ultrasound in the evaluation and management of individuals with spinal cord injuries (SCI), emphasizing its potential to address limitations in current diagnostic methods. The discussion will include the drawbacks of traditional approaches such as NCS/EMG and the advantages of ultrasound for respiratory function assessment, ventilator weaning evaluation, and candidacy for diaphragmatic pacers. Attendees will also explore innovative models for integrating ultrasound into clinical practice and potential avenues for future research. With presentations by Dr. Adewuyi, Dr. Franz, Dr. Bhatia, and Dr. Stone, this session will provide a comprehensive overview of current uses, limitations, and emerging opportunities for ultrasound technology in SCI care.
Learing Objectives
Learning Objective 1: Describe the limitations of current evaluation methods, including NCS/EMG, in assessing respiratory function and nerve activity in individuals with spinal cord injuries (SCI).
Learning Objective 2: Explain why ultrasound is an effective diagnostic tool in SCI care, particularly for evaluating ventilator weaning and assessing diaphragmatic pacer candidacy.
Learning Objective 3:Identify key clinical applications and benefits of using ultrasound for evaluating respiratory function and other SCI-related complications.
Learning Objective 4: Demonstrate how ultrasound can be integrated into clinical practice, using real-world models and examples provided by experts in the field.
Learning Objective 5: Evaluate potential avenues for further research and technological advancements in ultrasound for spinal cord injury care.
Member Community:
Spinal Cord Injury Medicine & Neuromusuclar EDX
Faculty
Session Director: Shane Stone, MD, FAAPMR, Disclosed no relevant financial relationships.
Colin Franz, MD/PhD, FAAPMR
Adenike Adewuyi, MD/PhD, Disclosed no relevant financial relationships.
Natasha Bhatia, MD, Disclosed no relevant financial relationships.
AAPM&R Medical Education Committee
John C. Cianca, MD: Ownership or partnership with Musculoskeletal Ultrasound Consultants, LLC.
Karen P. Barr, MD: Disclosed no relevant financial relationships.
Rachel A. Brakke Holman, MD: Disclosed no relevant financial relationships.
Joseph E. Burris, MD: Serves on the Speakers Bureau for, and received clinical research grants from Allergan.
David S. Cheng, MD: Disclosed no relevant financial relationships.
Theresa A. Gillis, MD: Disclosed no relevant financial relationships.
Kevin N. Hakimi, MD: Disclosed no relevant financial relationships.
Matthew T. Haas, MD: Disclosed no relevant financial relationships.
R.Samuel Mayer, MD: Royalties from Demos Medical Publishing.
Ameet S. Nagpal, MD MS MEd: Disclosed no relevant financial relationships.
Sunil Sabharwal, MD: Royalities from Demos Publishing; board member, American Board of Physical Medicine and Rehabilitation.
Sarah M. Smith, MD: Disclosed no relevant financial relationships.
Stephanie Tow, MD: Disclosed no relevant financial relationships.
Kevin R. VIncent, MD, PhD: Disclosed no relevant financial relationships.
AAPM&R CME Committee
Karen P. Barr, MD: Disclosed no relevant financial relationships.
Cherry C. Junn, MD: Disclosed no relevant financial relationships.
Sheryl R. Levin, MD: Disclosed no relevant financial relationships.
Kentaro Onishi, DO: Disclosed no relevant financial relationships.
Evan R. Peck, MD: Disclosed no relevant financial relationships.
Cynthia G. Pineda, MD: Disclosed no relevant financial relationships.
Patricia T. Tan, MD: Disclosed no relevant financial relationships.
Brionn K. Tonkin, MD: Disclosed no relevant financial relationships.
Kristin A. Wong, MD: Disclosed no relevant financial relationships.
No other planners, faculty or other individuals in control of content disclosed any relevant financial relationships.
FDA Disclosures
All faculty members for this activity have disclosed they do not intend to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved.